|
|
|
| Association between frailty and type 2 diabetes mellitus: a Mendelian randomization study |
| CUI Yanze, ZHANG Ling, JIANG Lu, LI Huimin, WANG Shuo
|
| School of Nursing, Xuzhou Medical University, Xuzhou, Jiangsu 221000, China |
|
|
|
|
Abstract Objective To investigate the association between frailty and type 2 diabetes mellitus (T2DM) using a bidirectional two-sample Mendelian randomization (MR) analysis, so as to provide the evidence for the prevention and control of frailty and T2DM. Methods Frailty status was assessed using the Fried Frailty Score (FFS), with aggregated data sourced from 386 565 European samples in the UK Biobank. The T2DM data were obtained from the summary results of genome-wide analysis published by the Diabetes Genetics Replication and Meta-analysis Consortium, excluding the UK Biobank data, including 455 313 European samples. Eligible single nucleotide polymorphism site were selected from the FFS and T2DM summary data as instrumental variables. The bidirectional MR analysis was performed using the inverse-variance weighted method. The heterogeneity was assessed using the modified Cochran Q test. The horizontal pleiotropy of instrumental variables was examined using MR-Egger regression. The robustness of the results was evaluated using the leave-one-out method. The bias was tested using funnel plot. Results The forward MR analysis revealed a statistically significant association between increased FFS and an increased risk of T2DM (OR=2.280, 95%CI: 1.169-4.447). The reverse MR analysis showed a statistically significant association between T2DM and increased FFS (β=0.026, 95%CI: 0.012-0.041). Both bidirectional MR results were robust, with no horizontal pleiotropy of the instrumental variables was found (all P>0.5); and the funnel plots did not show significant basis. Conclusion The study found a bidirectional causal association between frailty and T2DM.
|
|
Received: 28 March 2024
Revised: 15 June 2024
Published: 18 September 2024
|
|
|
|
|
|
[1] DOODY P,LORD J M,GREIG C A,et al.Frailty:pathophysiology,theoretical and operational definition(s),impact,prevalence,management and prevention,in an increasingly economically developed and ageing world[J]. Gerontology,2023,69(8):927-945.
[2] KONG L N,LYU Q,YAO H Y,et al.The prevalence of frailty among community-dwelling older adults with diabetes:a meta-analysis[J/OL]. Int J Nurs Stud,2021,119[2024-06-15]. https://doi.org/10.1016/j.ijnurstu.2021.103952.
[3] 尚轶,高倩倩,陈飞,等. 衰弱老年人糖尿病患病率的系统评价[J]. 中国循证医学杂志,2021,21(7):825-831.
[4] 王晓薇,许艳岚. 老年2型糖尿病患者认知衰弱风险预测研究[J]. 预防医学,2023,35(12):1037-1042.
[5] VERONESE N,STUBBS B,FONTANA L,et al.Frailty is associated with an increased risk of incident type 2 diabetes in the elderly[J]. J Am Med Dir Assoc,2016,17(10):902-907.
[6] CHHETRI J K,ZHENG Z,XU X T,et al. The prevalence and incidence of frailty in pre-diabetic and diabetic community-dwelling older population:results from Beijing Longitudinal Study of Aging Ⅱ(BLSA-Ⅱ)[J/OL]. BMC Geriatr,2017,17(1)[2024-06-15]. https://doi.org/10.1186/s12877-017-0439-y.
[7] FRIED L P,TANGEN C M,WALSTON J,et al.Frailty in older adults:evidence for a phenotype[J]. J Gerontol A Biol Sci Med Sci,2001,56(3):146-157.
[8] YE Y,NOCHE R B,SZEJKO N,et al.A genome-wide association study of frailty identifies significant genetic correlation with neuropsychiatric,cardiovascular,and inflammation pathways[J]. Geroscience,2023,45(4):2511-2523.
[9] MAHAJAN A,TALIUN D,THURNER M,et al.Fine-mapping type 2 diabetes loci to single-variant resolution using high-density imputation and islet-specific epigenome maps[J]. Nat Genet,2018,50(11):1505-1513.
[10] LIU Q,PAN J,BERZUINI C,et al. Integrative analysis of Mendelian randomization and Bayesian colocalization highlights four genes with putative BMI-mediated causal pathways to diabetes[J/OL]. Sci Rep,2020,10(1)[2024-06-15]. https://doi.org/10.1038/s41598-020-64493-4.
[11] GU Y Z,LI Z Z,DANG A M,et al.Obesity,birth weight,and lifestyle factors for frailty:a Mendelian randomization study[J]. Aging(Albany NY),2023,15(23):14066-14085.
[12] CAO L M,WEN Y H,FAN K Y,et al. Association of birth weight with type 2 diabetes mellitus and the mediating role of fatty acids traits:a two-step Mendelian randomization study[J/OL]. Lipids Health Dis,2024,23(1)[2024-06-15]. https://doi.org/10.1186/s12944-024-02087-z.
[13] HEMANI G,ZHENG J,ELSWORTH B,et al. The MR-Base platform supports systematic causal inference across the human phenome[J/OL]. Elife,2018,7[2024-06-15]. https://doi.org/10.7554/eLife.34408.
[14] ZHU J H,ZHOU D,WANG J,et al. Frailty and cardiometabolic diseases:a bidirectional Mendelian randomisation study[J/OL]. Age Ageing,2022,51(11)[2024-06-15]. https://doi.org/10.1093/ageing/afac256.
[15] CESARI M,GAMBASSI G,VAN KAN G A,et al. The frailty phenotype and the frailty index:different instruments for different purposes[J]. Age Ageing,2014,43(1):10-12.
[16] ATKINS J L,JYLHÄVÄ J,PEDERSEN N L,et al. A genome-wide association study of the frailty index highlights brain pathways in ageing[J/OL]. Aging Cell,2021,20(9)[2024-06-15]. https://doi.org/10.1111/acel.13459.
[17] WU Y J,XIONG T,TAN X,et al. Frailty and risk of microvascular complications in patients with type 2 diabetes:a population-based cohort study[J/OL]. BMC Med,2022,20(1)[2024-06-15]. https://doi.org/10.1186/s12916-022-02675-9.
[18] O'DONOVAN M,SEZGIN D,O'CAOIMH R,et al. The impact of and interaction between diabetes and frailty on psychosocial wellbeing and mortality in Ireland[J/OL]. Int J Environ Res Public Health,2020,17(24)[2024-06-15]. https://doi.org/10.3390/ijerph17249535.
[19] JANG H C.Sarcopenia,frailty,and diabetes in older adults[J]. Diabetes Metab J,2016,40(3):182-189. |
|
|
|
